Project Grant HT94252510856
Award Date
10/1/25
Completion Date
9/30/28
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This federal Project Grant award of $2,469,162.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Wake Forest University Health Sciences (WFUHS) to investigate medical solutions for the battlefield and transform healthcare for military service members, veterans, and the public. The award will fund research on using allograft versus autograft to improve timely return to duty following nonunion, with a...
This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,477,108 to Wake Forest University Health Sciences to conduct research on single-implant versus dual-implant fixation of distal femur extra-articular and complete articular fractures. The project will run from September 30, 2023 through September 29, 2027. Wake Forest University Health Sciences, an academic medical center, will lead this research...
This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...
This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...
This federal Project Grant award, with a total funding amount of $480,313, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will support research conducted by Duke University, a leading private research institution, to investigate NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by...
This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...